Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
about
CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndromeα(M)β(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro.The role of chemokines in Guillain-Barré syndrome.A Brain-Derived Neurotrophic Factor-Based p75NTR Peptide Mimetic Ameliorates Experimental Autoimmune Neuritis Induced Axonal Pathology and Demyelination.FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies.Myelin ultrastructure of sciatic nerve in rat experimental autoimmune neuritis model and its correlation with associated protein expression.Translational strategies in peripheral neuroinflammation and neurovascular repair.The pathogenic relevance of αM-integrin in Guillain-Barré syndrome.Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.Berberine ameliorates experimental autoimmune neuritis by suppressing both cellular and humoral immunity.Behavioral, electrophysiological, and histopathological characterization of a severe murine chronic demyelinating polyneuritis model.Pioglitazone, PPARγ agonist, attenuates experimental autoimmune neuritis.Systemic IGF-1 gene delivery by rAAV9 improves spontaneous autoimmune peripheral polyneuropathy (SAPP).Cerebrospinal fluid under non-steady state condition caused by plasmapheresis
P2860
Q28540888-61B744B6-B710-4221-B470-6F851197E1F2Q30524065-FE6DB191-24B9-4892-BEA7-33CDD8B4B30DQ33624382-264FF693-A031-477E-9E62-B501DBA8F9F9Q33868439-9A658D28-6E0F-4912-A4EF-DD7A6E08F94BQ35305030-9C713E15-BF48-461C-8D79-2D6D09922485Q36014183-F8B957F9-56D2-4B38-A2AF-FD592D73D6D7Q36802945-A0DC9E0F-A80C-437B-864B-F7A11925D24CQ39558493-AD9127AF-4ABE-4B0F-8DF0-7CD0DFB50D6AQ40444924-169967D4-2B77-459E-9195-17CC43728754Q43497937-4B91EEA6-04EA-4183-9A94-32D8AC213BFAQ49470841-FDE4DA2B-8DB3-4247-BD54-26CFCBF7743CQ53651047-DF4AE010-2F68-417C-B5FE-55D01A2D5475Q54242491-5873750E-519F-47F6-8F64-74BED3A47855Q57780150-F2C84A9C-6A97-48D0-8832-30E43EF617AF
P2860
Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Clinical, electrophysiological ...... el of Guillain-Barré syndrome.
@en
Clinical, electrophysiological ...... el of Guillain-Barré syndrome.
@nl
type
label
Clinical, electrophysiological ...... el of Guillain-Barré syndrome.
@en
Clinical, electrophysiological ...... el of Guillain-Barré syndrome.
@nl
prefLabel
Clinical, electrophysiological ...... el of Guillain-Barré syndrome.
@en
Clinical, electrophysiological ...... el of Guillain-Barré syndrome.
@nl
P2093
P1476
Clinical, electrophysiological ...... el of Guillain-Barré syndrome.
@en
P2093
Eroboghene E Ubogu
Nejla Yosef
Robin H Xia
P356
10.1016/J.JNEUROIM.2009.11.019
P577
2010-01-19T00:00:00Z